首页> 外文期刊>Journal of infection and public health. >In vitro antimicrobial synergy studies of carbapenem-resistant Acinetobacter baumannii isolated from intensive care units of a tertiary care hospital in Egypt
【24h】

In vitro antimicrobial synergy studies of carbapenem-resistant Acinetobacter baumannii isolated from intensive care units of a tertiary care hospital in Egypt

机译:从埃及一家三级护理医院的重症监护室分离出的耐碳青霉烯类鲍曼不动杆菌的体外抗菌协同研究

获取原文
获取原文并翻译 | 示例
           

摘要

The increasing prevalence of multidrug-resistant and pan drug-resistant Acinetobacter baumannii as a cause of nosoconnial infections has led to the need for the reassessment of novel combinations of antibiotics as our only current viable option for handling such infections until a new therapeutic option becomes available. Two of the most commonly used methods for testing antimicrobial synergy are the Time-kill assay method and the E-test method, and these were the methods used in this study. Antibiotic combinations tested in this study were azithromycin and polymyxin, tobrannycin and polymyxin, polynnyxin and rifampicin, and tobramycin and rifampicin.
机译:多重耐药性和泛耐药性鲍曼不动杆菌作为医院感染的原因,这导致我们需要重新评估新型抗生素组合,这是我们目前唯一可行的应对此类感染的选择,直到有新的治疗选择。测试抗菌协同作用的两种最常用方法是时间杀灭测定法和E检验法,这是本研究中使用的方法。在这项研究中测试的抗生素组合为阿奇霉素和多粘菌素,妥布霉素和多粘菌素,多粘菌素和利福平,以及妥布霉素和利福平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号